Abstract:BACKGROUND Aldosterone has been implicated in a variety of organ fibroses, but its role and mechanism in liver fibrosis remain unclear. METHODS Rat primary hepatic stellate cells (HSCs) were isolated, cultured, and characterized. HSCs were incubated with aldosterone (10(-6) M) for 4 h, 8 h, 12 h, 24 h, and 48 h, after which TGF-β1 (transforming growth factor beta 1) expression was measured by real-time PCR. Rat HSCs were treated with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M), and the expressions of PAI-1 (plasminogen activator inhibitor-1) and TGF-β1 were determined by measuring mRNA and protein. HSCs were incubated in groups containing aldosterone (10(-6) M), spironolactone (10(-5) M), both aldosterone and spironolactone, or neither aldosterone nor spironolactone (control), after which mRNA and protein expression of PAI-1 and TGF-β1 were measured. Collagen I expression was detected by immunohistochemical analysis of supernatants of the aldosterone (10(-6) M), TGF-β1, and aldosterone plus TGF-β1 groups. SMAD expression was detected in rat HSC control, HSC plus aldosterone (10(-6) M), HSC plus TGF-β1, and HSC plus aldosterone plus TGF-β1 groups. RESULTS HSCs were incubated with aldosterone for 4 h, 8 h, 12 h, 24 h, and 48 h after which TGF-β1 expression was measured. We found that TGF-β1 expression increased in a time dependent manner and reached a peak at 24 h. The expression of TGF-β1 in groups treated with aldosterone for 4 h, 8 h, 12 h, and 24 h was significantly different from the control group (P < 0.01). No significant difference was seen in TGF-β1 expression between the groups treated with aldosterone for 24 h and 48 h (P > 0.05). Compared with the control group, TGF-β1 expression was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). There were significant differences in the expression of TGF-β1 between 10(-6) M and 10(-7) M aldosterone treatment groups (P < 0.01). Compared with the control group, the expression of PAI-1 was significantly increased after incubation with different concentrations of aldosterone (10(-6) M, 10(-7) M, 10(-8) M, and 10(-9) M) (P < 0.01). PAI-1 expression was increased in the aldosterone, spironolactone, and aldosterone plus spironolactone groups. The expression of PAI-1 was significantly enhanced in the aldosterone and aldosterone plus spironolactone groups compared with the control group (P < 0.01). There was a marked enhancement of collagen I expression in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). Collagen I expressions in the aldosterone and TGF-β1 groups were significantly different from the aldosterone plus TGF-β1 group (P < 0.01). Compared with the control group, SMAD expression was markedly elevated in the aldosterone, TGF-β1, and aldosterone plus TGF-β1 groups (P < 0.05). The expression of SMAD was significantly increased in the aldosterone plus TGF-β1 group compared with the aldosterone group (P < 0.01). CONCLUSION This study demonstrated that aldosterone promoted HSC activation and the expression of TGF-β1, PAI-1, and collagen in hepatic fibrosis progression and that spironolactone administration partially reversed the effects. The aldosterone promotional effect on hepatic fibrosis was partially mediated by TGF-β1.

Inhibitory Effect of Human Interferon‐beta‐1a on Activated Rat and Human Hepatic Stellate Cells

Different Effects of Rat Interferon Alpha, Beta and Gamma on Rat Hepatic Stellate Cell Proliferation and Activation.

[Effect of Glia Maturation Factor Beta on the Activation of Hepatic Stellate Cells and on Liver Fibrosis].

Targeting Transforming Growth Factor Βrii Expression Inhibits the Activation of Hepatic Stellate Cells and Reduces Collagen Synthesis

In Vitro Study on the Role and Mechanism of Interferon Α-1B in Regulating the Inhibition of Protein Kinase Cεand Cα on Fibrosis of Hepatic Stellate Cells

Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells

Liver Fibrosis and Hepatic Stellate Cells Improvement of Chronic Hepatitis C Patients by Interferon-Beta-1a with or Without Sustained Viral Response.

Effect of Recombinant Human Growth Hormone and Interferon Gamma on Hepatic Collagen Synthesis and Proliferation of Hepatic Stellate Cells in Cirrhotic Rats

The effect of antifibrotic drug halofugine on Th17 cells in concanavalin A-induced liver fibrosis.

Effect of Aldosterone and Its Antagonist on the Expression of PAI-1 and TGF-β1 in Rat Hepatic Stellate Cells.

Effect of interfering RNA targeting high mobility group box chromosomal protein 1 on the biological characters of hepatic stellate cells

[Antifibrotic Effects of Cyclic RGD-peptide Mediated Liposomal Interferon: an Experimental on Rats].

Role of Macrophage Migration Inhibitory Factor in Hepatic Stellate Cells Activation

Effects of all-trans retinioc acid on expressions of COL1α2,MMP-2,TIMP-1, and signaling pathway in TGF-β1-simulated rat hepatic stellate cells

The Inhibitory Effects of Hjc0416 on Liver Fibrogenesis in Activated Hepatic Stellate Cells

Effects of Antisense Transforming Growth Factor Β Receptor-ⅰ Expressing Plasmid on Rat Activated Hepatic Stellate Cells in Vitro

Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.

[Effect of Pegylated Interferon Beta-1A Therapy on the Liver Fibrosis in Chronic Hepatitis C: a Semi-Quantitative Analysis].

RNA interfering connective tissue growth factor prevents rat hepatic stellate cell activation and extracellular matrix production.

Effect of Shrna-Mediated Silencing of CTGF and TIMP-1 on Mrna Expression of CTGF, TIMP-1, and PCI and Secretion of Extracellular Matrix in Rat Hepatic Stellate Cells

Effect of silencing connective tissue growth factor by small interfering RNA on culture-activated rat hepatic stellate cells